Physiologic Peptide Cyclization in Myeloid Cells
Physiologic Peptide Cyclization in Myeloid Cells
批准号:
6823638
负责人:
MICHAEL E SELSTED
金额:
$37.88万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-06-01 至 2009-05-31
关键词:
antibioticsbiochemistrycyclic peptidesdefensinselectrophoresiselectrospray ionization mass spectrometryenzyme substratehigh performance liquid chromatographyimmunoelectron microscopyimmunoprecipitationmatrix assisted laser desorption ionizationmolecular assembly /self assemblymolecular biologymonocyteposttranslational modificationsprotein protein interactionrecombinant proteinstissue /cell cultureyeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Defensins are tridisulfide peptides implicated in innate immunity against potentially pathogenic microorganisms. Myeloid defensins are packaged in the granules of neutrophils and monocytes, and epithelial defensins are expressed in a wide variety of mucosal tissues. The most recently discovered defensins, termed theta-defensins, are 18-amino acid macrocyclic peptides that are stabilized by three parallel disulfide bonds. Isolated from rhesus monkey leukocytes, theta-defensins are remarkably potent antibiotics that kill bacteria and fungi, and they inactivate HIV-1. Antimicrobial activity is abrogated by opening of the backbone ring. The presence of macrocyclic peptides in animals was not previously known. Moreover, the biosynthesis of theta-defensins is novel, as the cyclic peptide is synthesized from two 9-amino acid segments that are spliced together in a head-to-tail configuration. While the cellular machinery that mediates this post-translational pathway is unknown, we hypothesize that enzymes expressed in theta-defensin-producing cells are responsible for the nonapeptide excision and ligation steps necessary for biosynthesis of the mature cyclic molecule. We propose to characterize the molecular components of the theta-defensin processing pathway by pursuing three specific Aims:
1. In Specific Aim 1, we will analyze the pro-theta-defensin intermediates produced in myeloid cells, and will determine the subcellular compartments of the molecular intermediates identified.
2. Specific Aim 2 is to identify pro-theta-defensin converting activities in extracts of theta-defensin-expressing cells. For these studies we will use synthetic and recombinant forms of putative substrates involved in the excision/ligation pathway, and use immunoprecipitation, and chromatographic, electrophoretic, and mass spectroscopic methods for detecting and characterizing the relevant enzymatic activities.
3. Specific Aim 3 is to characterize proteins that interact with pro-theta-defensins and subsequent intermediates, as these are likely to be convertases or chaperones necessary for the excision/ligation steps involved in theta-defensin biosynthesis.
Results obtained from these studies are likely to disclose novel mechanisms that have evolved for splicing and cyclizing proteins in mammalian cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of Mucosal Immunity by Pro- and Anti-inflammatory Salivary Defensins
-
批准号:8127613
-
项目类别:
-
资助金额:$38.11万
-
财政年份:2010
-
负责人:MICHAEL E SELSTED
-
依托单位:
Regulation of Mucosal Immunity by Pro- and Anti-inflammatory Salivary Defensins
-
批准号:8665891
-
项目类别:
-
资助金额:$38.89万
-
财政年份:2010
-
负责人:MICHAEL E SELSTED
-
依托单位:
Regulation of Mucosal Immunity by Pro- and Anti-inflammatory Salivary Defensins
-
批准号:8269132
-
项目类别:
-
资助金额:$38.89万
-
财政年份:2010
-
负责人:MICHAEL E SELSTED
-
依托单位:
Regulation of Mucosal Immunity by Pro- and Anti-inflammatory Salivary Defensins
-
批准号:8462591
-
项目类别:
-
资助金额:$37.34万
-
财政年份:2010
-
负责人:MICHAEL E SELSTED
-
依托单位:
MOLECULAR ONTOGENY OF ORAL MUCOSAL RESISTANCE TO SIV
-
批准号:7716117
-
项目类别:
-
资助金额:$30.68万
-
财政年份:2008
-
负责人:MICHAEL E SELSTED
-
依托单位:
MOLECULAR ONTOGENY OF ORAL MUCOSAL RESISTANCE TO SIV
-
批准号:7349715
-
项目类别:
-
资助金额:$15.67万
-
财政年份:2006
-
负责人:MICHAEL E SELSTED
-
依托单位:
Physiologic Peptide Cyclization in Myeloid Cells
-
批准号:7238738
-
项目类别:
-
资助金额:$36.15万
-
财政年份:2004
-
负责人:MICHAEL E SELSTED
-
依托单位:
Physiologic Peptide Cyclization in Myeloid Cells
-
批准号:7070049
-
项目类别:
-
资助金额:$37.23万
-
财政年份:2004
-
负责人:MICHAEL E SELSTED
-
依托单位:
Physiologic Peptide Cyclization in Myeloid Cells
-
批准号:7420995
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2004
-
负责人:MICHAEL E SELSTED
-
依托单位:
Physiologic Peptide Cyclization in Myeloid Cells
-
批准号:7112585
-
项目类别:
-
资助金额:$2.64万
-
财政年份:2004
-
负责人:MICHAEL E SELSTED
-
依托单位:
Physiologic Peptide Cyclization in Myeloid Cells
-
批准号:6894641
-
项目类别:
-
资助金额:$38.1万
-
财政年份:2004
-
负责人:MICHAEL E SELSTED
-
依托单位:
Molecular Ontogeny of Oral Mucosal Resistance to SIV
-
批准号:6833954
-
项目类别:
-
资助金额:$51.96万
-
财政年份:2003
-
负责人:MICHAEL E SELSTED
-
依托单位:
Molecular Ontogeny of Oral Mucosal Resistance to SIV
-
批准号:6994462
-
项目类别:
-
资助金额:$55.97万
-
财政年份:2003
-
负责人:MICHAEL E SELSTED
-
依托单位:
Molecular Ontogeny of Oral Mucosal Resistance to SIV
-
批准号:7151221
-
项目类别:
-
资助金额:$57.33万
-
财政年份:2003
-
负责人:MICHAEL E SELSTED
-
依托单位:
Molecular Ontogeny of Oral Mucosal Resistance to SIV
-
批准号:6695544
-
项目类别:
-
资助金额:$45.41万
-
财政年份:2003
-
负责人:MICHAEL E SELSTED
-
依托单位:
DRUG DISCOVERY FOR TREATMENT OF CRYPTOCOCCAL DISEASE
-
批准号:3547861
-
项目类别:
-
资助金额:$81.91万
-
财政年份:1991
-
负责人:MICHAEL E SELSTED
-
依托单位:
DRUG DISCOVERY FOR TREATMENT OF CRYPTOCCAL DISEASE
-
批准号:3547859
-
项目类别:
-
资助金额:$78.9万
-
财政年份:1991
-
负责人:MICHAEL E SELSTED
-
依托单位:
DRUG DISCOVERY FOR TREATMENT OF CRYPTOCOCCAL DISEASE
-
批准号:3547860
-
项目类别:
-
资助金额:$78.83万
-
财政年份:1991
-
负责人:MICHAEL E SELSTED
-
依托单位:
DRUG DISCOVERY FOR TREATMENT OF CRYPTOCOCCAL DISEASE
-
批准号:2066666
-
项目类别:
-
资助金额:$68.44万
-
财政年份:1991
-
负责人:MICHAEL E SELSTED
-
依托单位:
MOLECULAR ASPECTS OF LEUKOCYTE ANTIMICROBIAL PEPTIDES
-
批准号:6510343
-
项目类别:
-
资助金额:$37.6万
-
财政年份:1989
-
负责人:MICHAEL E SELSTED
-
依托单位:
海外基金